BioDelivery Sciences names new CFO
This article was originally published in Scrip
Executive Summary
BioDelivery Sciences International – headquartered in Raleigh, North Carolina – has appointed Ernest R De Paolantonio chief financial officer and corporate secretary. Prior to joining the firm, a specialty pharmaceutical company developing drug delivery technologies for therapies treating pain management and addiction, Mr De Paolantonio was CFO at privately held generic company CorePharma.
You may also be interested in...
Six New Molecules By 2030 – J&J’s Neuroscience Strategy
Can neuroscience be precise? Peter Fang, worldwide VP of neuroscience, explains J&J's approach to precision medicine in Alzheimer’s disease, depression and other neurological conditions.
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.